USE OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF BB-12 AND LGG IN THE PREPARATION OF A MEDICAMENT FOR PREVENTING OR TREATING RESPIRATORY INFECTIONS AND ACUTE OTITIS MEDIA IN INFANTIS

Application 4807/CHENP/2006 published 2007-10-05, filed 2006-12-29
The present invention is directed to a novel method for preventing or treating respiratory infections and acute otitis media in infartts. The method comprises the administration of a therapeutically effective amount of a Bifidobacteria strain and an adherence-promoting probiotic, such as LGG, to the infant.

Applicant

1)BRISTOL-MYERS SQUIBB COMPANY
:LAWRENCEVILLE-PRINCETON ROAD, PRINCETON, NJ 08543-4000, USA U.S.A.

Inventor

1)ISOLAURI, ERIKA 2)SALMINEN, SEPPO

International Info

Classification: A61K 35/74
Publication Number: WO 2006/007526 A1
Application Date: 2005-07-01

Priority Information

60/584,830 U.S.A. 2004-07-01